MicrobeWorld App

appsquarebannerad200x200

Microbes After Hours

WaterSupplyYouTubeFrame

Click for more "Microbes After Hours" videos

Join MicrobeWorld

Subscribe via Email

subscribe

Featured Image

Featured Video

Ebola Virus explained

Supporters

ASM House 200X200

Clues to Making Vaccine for Infant Respiratory Illness

RSV.jpg
Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have identified the structure of a critical RSV component called the fusion glycoprotein.

Respiratory syncytial virus, or RSV, is a respiratory virus that infects the lungs and breathing passages. Healthy individuals recover from RSV infection in 1 to 2 weeks. However, infection can be severe in some people, such as infants, young children, and older adults. RSV is the most common cause of bronchitis and pneumonia in children under 1 year of age in the United States. Understanding the structure of the RSV fusion glycoprotein allows scientist to also identify the site of antibody vulnerability on the virus. This new structural information will help scientist design vaccines that can elicit potent antibodies aimed at the vulnerability site of the virus.
 
 

Comments (0)

Collections (0)

 

American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
American Society For Microbiology © 2014   |   Privacy Policy   |   Terms of Use